Advertisement
Advertisement
September 23, 2015
Bolton Medical's Treo EVAR System Receives CE Mark Approval
September 24, 2015—Bolton Medical, a subsidiary of the WerfenLife Company, announced it has received European CE Mark approval for the Treo abdominal stent graft system for the endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms. Bolton Medical will begin a limited market release of Treo with selected customers in Europe beginning in October 2015. The company will officially launch Treo in January at LINC 2016, the Leipzig Interventional Course, in Leipzig, Germany.
According to the company, the Treo device is modularly designed as a three-piece system and is offered in a wide range of sizes. The Treo features dual proximal fixation and a proximal clasping mechanism. It was engineered to allow for accurate and controlled deployment and provide long-term stability of the stent graft.
In Bolton Medical’s press release, John Henretta, MD, of Carolina Vascular, commented, “Stent migration and endoleaks are major concerns in EVAR. The Treo stent graft offers both suprarenal and infrarenal fixation, distributing the attachment points in two different anatomical levels, which may work to reduce potential endoleaks, particularly in angulated necks. I expect this to lower reintervention rates in my practice.”
Advertisement
Advertisement
